Source comparison
Semax vs Selank: Frequently Asked Questions
The question doesn't have a direct answer because the two compounds are studied for different effects. Semax has been studied in cognitive and neuroprotective models; Selank in anxiolytic and stress-response models. Comparing them as if they are alternatives f
This comparison does not assign a generated winner or score.
- The question doesn't have a direct answer because the two compounds are studied for different effects. Semax has been studied in cognitive and neuroprotective models; Selank in anxiolytic and stress-response models. Comparing them as if they are alternatives for the same endpoint would be like comparing a stimulant to a sedative on a single scale. The relevant question is which compound is better matched to the specific research question.
- Semax is derived from a fragment of adrenocorticotropic hormone (ACTH) and has been primarily studied for cognitive and neuroprotective effects, with BDNF upregulation as a proposed mechanism. Selank is derived from tuftsin, an immune peptide, and has been primarily studied for anxiolytic and immunomodulatory effects via GABAergic pathways. They share a nasal-spray format and a Russian research origin but are structurally unrelated.
- A blended nasal-spray format containing both compounds is available for research use. The theoretical basis for combining them rests on their different mechanisms acting on complementary systems. No published controlled study has characterized the pharmacological interaction between the two, so researchers should treat the combination as an area requiring investigation rather than an established protocol.
- Both are registered pharmaceutical drugs in Russia, used there for neurological and psychiatric indications respectively. Neither is approved by the U.S. FDA or the European Medicines Agency. Outside Russia and Ukraine, both are classified as unapproved research peptides — available for laboratory and preclinical research use only, not for human consumption.
- Both compounds are available as nasal-spray and injectable-vial formats for research use. The nasal-spray format is more common in the published behavioral literature because it is thought to allow more direct CNS access via olfactory pathways. Each is available with lot-specific Certificate of Analysis documentation. For research use only.